|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Although autologous blood collections have become popular, the costs associated with their collection are higher than those associated with the collection of allogeneic blood. The continued need for autologous blood programs has been questioned because the reduced risk of allogeneic blood transfusions has made PAD poorly cost-effective.[47] [48] [49]
|
|
|
|
|
|
|
|
|
|
|
|
|
